Literature DB >> 20646842

Dosimetric effect of intrafraction motion and residual setup error for hypofractionated prostate intensity-modulated radiotherapy with online cone beam computed tomography image guidance.

Justus Adamson1, Qiuwen Wu, Di Yan.   

Abstract

PURPOSE: To quantify the dosimetric effect and margins required to account for prostate intrafractional translation and residual setup error in a cone beam computed tomography (CBCT)-guided hypofractionated radiotherapy protocol. METHODS AND MATERIALS: Prostate position after online correction was measured during dose delivery using simultaneous kV fluoroscopy and posttreatment CBCT in 572 fractions to 30 patients. We reconstructed the dose distribution to the clinical tumor volume (CTV) using a convolution of the static dose with a probability density function (PDF) based on the kV fluoroscopy, and we calculated the minimum dose received by 99% of the CTV (D(99)). We compared reconstructed doses when the convolution was performed per beam, per patient, and when the PDF was created using posttreatment CBCT. We determined the minimum axis-specific margins to limit CTV D(99) reduction to 1%.
RESULTS: For 3-mm margins, D(99) reduction was ≤5% for 29/30 patients. Using post-CBCT rather than localizations at treatment delivery exaggerated dosimetric effects by ~47%, while there was no such bias between the dose convolved with a beam-specific and patient-specific PDF. After eight fractions, final cumulative D(99) could be predicted with a root mean square error of <1%. For 90% of patients, the required margins were ≤2, 4, and 3 mm, with 70%, 40%, and 33% of patients requiring no right-left (RL), anteroposterior (AP), and superoinferior margins, respectively.
CONCLUSIONS: For protocols with CBCT guidance, RL, AP, and SI margins of 2, 4, and 3 mm are sufficient to account for translational errors; however, the large variation in patient-specific margins suggests that adaptive management may be beneficial.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646842      PMCID: PMC3010484          DOI: 10.1016/j.ijrobp.2010.02.033

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Inclusion of geometric uncertainties in treatment plan evaluation.

Authors:  Marcel van Herk; Peter Remeijer; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-04-01       Impact factor: 7.038

2.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

3.  Tracking the dose distribution in radiation therapy by accounting for variable anatomy.

Authors:  B Schaly; J A Kempe; G S Bauman; J J Battista; J Van Dyk
Journal:  Phys Med Biol       Date:  2004-03-07       Impact factor: 3.609

4.  Synchronized dynamic dose reconstruction.

Authors:  Dale W Litzenberg; Scott W Hadley; Neelam Tyagi; James M Balter; Randall K Ten Haken; Indrin J Chetty
Journal:  Med Phys       Date:  2007-01       Impact factor: 4.071

5.  Prostate intrafraction motion evaluation using kV fluoroscopy during treatment delivery: a feasibility and accuracy study.

Authors:  Justus Adamson; Qiuwen Wu
Journal:  Med Phys       Date:  2008-05       Impact factor: 4.071

6.  Quantifying the interplay effect in prostate IMRT delivery using a convolution-based method.

Authors:  Haisen S Li; Indrin J Chetty; Timothy D Solberg
Journal:  Med Phys       Date:  2008-05       Impact factor: 4.071

7.  A study of prostate delineation referenced against a gold standard created from the visible human data.

Authors:  Zhanrong Gao; David Wilkins; Libni Eapen; Christopher Morash; Youssef Wassef; Lee Gerig
Journal:  Radiother Oncol       Date:  2007-09-06       Impact factor: 6.280

8.  How low is the alpha/beta ratio for prostate cancer?

Authors:  Henk B Kal; Marion P R Van Gellekom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

9.  Dosimetric consequences of intrafraction prostate motion.

Authors:  Haisen S Li; Indrin J Chetty; Charles A Enke; Ryan D Foster; Twyla R Willoughby; Patrick A Kupellian; Timothy D Solberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-30       Impact factor: 7.038

10.  Intrafraction motion of the prostate during external-beam radiation therapy: analysis of 427 patients with implanted fiducial markers.

Authors:  Alexis N T J Kotte; Pieter Hofman; Jan J W Lagendijk; Marco van Vulpen; Uulke A van der Heide
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-21       Impact factor: 7.038

View more
  19 in total

1.  Evaluations of an adaptive planning technique incorporating dose feedback in image-guided radiotherapy of prostate cancer.

Authors:  Han Liu; Qiuwen Wu
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Hypofractionated proton therapy for prostate cancer: dose delivery uncertainty due to interfractional motion.

Authors:  Yi Wang; Jason A Efstathiou; Hsiao-Ming Lu; Gregory C Sharp; Alexei Trofimov
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

3.  Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy : Comparison of gold marker-based registrations with native MVCT.

Authors:  Peter Wust; Marc Joswig; Reinhold Graf; Dirk Böhmer; Marcus Beck; Thomasz Barelkowski; Volker Budach; Pirus Ghadjar
Journal:  Strahlenther Onkol       Date:  2017-05-02       Impact factor: 3.621

4.  Incorporating imaging information from deep neural network layers into image guided radiation therapy (IGRT).

Authors:  Wei Zhao; Bin Han; Yong Yang; Mark Buyyounouski; Steven L Hancock; Hilary Bagshaw; Lei Xing
Journal:  Radiother Oncol       Date:  2019-07-11       Impact factor: 6.280

5.  The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans.

Authors:  Katja M Langen; Bhavin Chauhan; Jeffrey V Siebers; Joseph Moore; Patrick A Kupelian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-06       Impact factor: 7.038

6.  Measurement of patient imaging dose for real-time kilovoltage x-ray intrafraction tumour position monitoring in prostate patients.

Authors:  James K Crocker; Jin Aun Ng; Paul J Keall; Jeremy T Booth
Journal:  Phys Med Biol       Date:  2012-04-20       Impact factor: 3.609

7.  A method of dose reconstruction for moving targets compatible with dynamic treatments.

Authors:  Per Rugaard Poulsen; Mai Lykkegaard Schmidt; Paul Keall; Esben Schjodt Worm; Walther Fledelius; Lone Hoffmann
Journal:  Med Phys       Date:  2012-10       Impact factor: 4.071

8.  Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy.

Authors:  T Langsenlehner; C Döller; P Winkler; G Gallé; K S Kapp
Journal:  Strahlenther Onkol       Date:  2013-02-28       Impact factor: 3.621

9.  Assessing the dosimetric impact of real-time prostate motion during volumetric modulated arc therapy.

Authors:  Juan Diego Azcona; Lei Xing; Xin Chen; Karl Bush; Ruijiang Li
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-01       Impact factor: 7.038

10.  Reducing margins for abdominopelvic tumours in dogs: Impact on dose-coverage and normal tissue complication probability.

Authors:  Valeria Meier; Chris Staudinger; Stephan Radonic; Jürgen Besserer; Uwe Schneider; Linda Walsh; Carla Rohrer Bley
Journal:  Vet Comp Oncol       Date:  2021-01-06       Impact factor: 2.613

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.